Page 23 - V Imaging News Today

Mortality from sudden cardiac death was no greater in low-risk athletes with HCM who continued high-intensity exercise than in the general population.

Patients with heart failure and mitral regurgitation should get at least 6 months of optimized guideline-directed medical therapy before invasive mitral repair is considered, researchers say.

Heart failure with preserved ejection fraction is common in people with type 2 diabetes but is often hard to recognize. Treatments newly proven to be effective make diagnosis an imperative.

In a new analysis of the FAME 3 trial, post-PCI fractional flow reserve predicted both target vessel failure and the risk of cardiac events.

Coronary angiography in patients who have previously had CABG surgery can be streamlined and made safer by preplanning using CT coronary angiography, results of the BYPASS-CTCA trial show.

The consensus addresses current gaps in recommendations on the role of cardiac CT in the guidance of care in patients with cancer -- as well as survivors.

The sham-controlled study found clinical outcomes improved incrementally over time, compared with PCI guided by angiographic assessment of lesions.

The diagnostic algorithm has been revamped and clinicians should be thinking of arterial hypertension at an earlier (lower) arterial pulmonary pressure, the authors say.

Abbotts MitraClip G4 device showed the lowest all-cause mortality to date in for transcatheter mitral valve replacement in a postmarket study.

Transcatheter edge-to-edge repairs were associated with lower mortality and hospitalization in an analysis of a large, international registry.